Dr. Reddy’s Laboratories Ltd ADR (RDY) is a Healthcare · Drug Manufacturers - Specialty & Generic company listed on NYSE. Price $12.19 (+0.00%), Market cap $11.36B, P/E ratio 25.68, 52-week low–high $12.46 ~ $16.17.
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. The Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredien
Financial statements, price targets, institutional (13F) holdings and related news for Dr. Reddy’s Laboratories Ltd ADR are updated in real time on BlackAll Trade.
Dr. Reddy’s Laboratories Ltd ADR trades at $12.19 (+0.00%). Real-time quotes and charts are available on BlackAll Trade.
Dr. Reddy’s Laboratories Ltd ADR has a market cap of about $11.36B. Its P/E ratio is 25.68.
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. It operates through Global